PODCAST

Neurology and Neurosurgery

ReachMD

science & medicine medicine

All Episodes

00:00:00

Primary Neurologically Hospitalized Patient: Internal...

Neurology and Neurosurgery ·

2024/04/12

Guest: Erick Tarula, MD Many complications can occur in hospitalized neurological patients from an internal medicine standpoint. So a session from the 2024 Academy of American Neurology (AAN) Annual Meeting focused on these common issues, how they can be addressed quickly, and the role of a neurohospitalist. Dive in further with Dr. Erick Tarula, Assistant Professor in the Department of Neurology at the University of Wisconsin School of Medicine and Public Health.

00:00:00

The Gene Messenger: Advancing Neurological Gene Therapy

Neurology and Neurosurgery ·

2024/04/12

Guest: Michael Kaplitt, MD, PhD For the first time, Dr. Michael Kaplitt was able to perform a trial for a neurological gene therapy that was administered in a human patient to address damaged brain cells caused by Parkinson’s disease. This procedure used an adeno-associated virus to deliver a gene into the brain of a patient with Parkinson’s. The results were groundbreaking and paved new avenues for research in neurological gene therapy, such as preventative intervention. Join health

00:00:00

Recognizing and Addressing Medical Gaslighting in...

Neurology and Neurosurgery ·

2024/04/10

Host: Michele Longo, MD Medical gaslighting refers to the situation where a medical professional disregards an individual's health concerns. It most often affects patients suffering from neurological disorders like long COVID and MS, and it can be extremely damaging to the physician-patient relationship. This underscores the importance of knowing how to recognize and reduce medical gaslighting in clinical practice, which is why Dr. Michele Longo is here to discuss the “Healing Doubt:

00:00:00

The Network Effect: Analyzing Brain Structures to...

Neurology and Neurosurgery ·

2024/04/05

Guest: Conor Liston, MD, PhD For patients diagnosed with depression for the first time the recommended course of treatment is the same; however, there’s a large patient population for whom these treatments won’t work. So it became increasingly important for Dr. Liston to map the brains of people suffering from major depression to see how it was impacting brain structures and symptoms. The research showed that certain networks expanded in the brains of patients who had depression and

00:00:00

Exploring the Clinical Treatments of Schizophrenia

Neurology and Neurosurgery ·

2024/03/27

Host: Ashley Baker, MSN, PMHNP Guest: Nabil Ali, MD When it comes to treating patients with schizophrenia, it’s important to remember to not have one particular medication that you stick by at all times and to consider things like their personal history and their side effects. To learn more about the treatment algorithm when managing these patients, join in with Psychiatric Nurse Practitioner Ashley Baker as she speaks with Dr. Nabil Ali, Assistant Consulting Professor in the

00:00:00

The Role of Occupational Therapy in Schizophrenia...

Neurology and Neurosurgery ·

2024/03/26

Host: Ashley Baker, MSN, PMHNP Guest: Lauren Walker, OT Occupational therapists (OT) play a crucial role in the management of schizophrenia by focusing on enhancing the patient’s ability to engage in meaningful activities and daily life tasks. Working towards a goal that a patient has by breaking it down into smaller parts is one of the ways to help a patient be successful and spark motivation. Dive in further on how OT’s assist patients through first-episode psychosis and

00:00:00

Investigating the Prevalence of Comorbidities in MS...

Neurology and Neurosurgery ·

2024/03/22

Host: Ashley Baker, MSN, PMHNP Guest: Amber Salter, PhD In 2016, an International Advisory Committee on Clinical Trials in Multiple Sclerosis (MS) recommended that comorbidities be more clearly and consistently described in enrolled clinical trial populations for common comorbidities so we can better understand the applicability of these trial findings to those in clinical practice. And so a recent study investigated the prevalence of comorbidities in MS clinical trial populations

00:00:00

Assessing Disability in MS Patients with the SNRS and...

Neurology and Neurosurgery ·

2024/03/18

Host: Andrew Wilner, MD, FACP, FAAN Guest: Dejan Jakimovski, MD, PhD Despite the fact that categorial scores like the Expanded Disability Status Scale (EDSS) and the MS Severity Scale (MSSS) are considered to be the gold standard, a recent study found that the Scripps Neurological Rating Scale (SNRS) and the Combinatorial Weight-Adjusted Disability Score (CombiWISE) may be better suited for assessing disability in patients who are severely affected by MS. Learn more about this

00:00:00

Practices for Preventing Polypharmacy in Multiple...

Neurology and Neurosurgery ·

2024/03/13

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ahmed Zayed Obeidat, MD, PhD Guest: Lauren Beranek, BS Polypharmacy is defined as the regular use of five or more prescribed medications, and due to their disease course, related symptoms, and side effects, patients with multiple sclerosis are at an increased risk of polypharmacy. So to hear insights on ways to identify, manage, and prevent polypharmacy, Dr. Mary Catherine Cheeley is joined by Dr. Ahmed Obeidat,

00:00:00

From Assessment to Management: Tackling Catatonia in...

Neurology and Neurosurgery ·

2024/03/12

Host: Ashley Baker, MSN, PMHNP Guest: Stanley N. Caroff, MD Catatonia is a neuropsychiatric condition characterized by disturbances in psychomotor function, stemming from various disorders impacting brain function. And while catatonia is not specifically related to schizophrenia alone, it’s important to know how to recognize and treat schizophrenic patients with catatonic symptoms. That’s why psychiatric nurse practitioner Ashley Baker speaks with Dr. Stanley Caroff about his

00:00:00

Narcolepsy, Idiopathic Hypersomnia, and General Sleep...

Neurology and Neurosurgery ·

2023/12/05

Unknown: Rajkumar Dasgupta, MD In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.

00:00:00

Does Epstein-Barr Virus Cause MS?

Neurology and Neurosurgery ·

2021/12/17

Unknown: Patricia K. Coyle, MD, FAAN, FANA Unknown: Douglas R. Jeffrey, MD, PhD Is EBV the Cause of Multiple Sclerosis? Viruses have long been implicated in the pathogenesis of multiple sclerosis, but no single virus has been found to be the cause. Could Epstein-Barr Virus—or EBV—be the culprit? Listen to the experts debate!

00:00:00

Exploring Uncharted Areas of the Brain: The...

Neurology and Neurosurgery ·

2019/03/01

Host: Andrew Wilner, MD, FACP, FAAN Guest: George Paxinos, MD Generations after Camillo Golgi developed the staining technique enabling scientists to visualize individual neurons as well as their axons and dendrites, some groundbreaking discoveries are again coming to light—like the one neuroscientist Dr. George Paxinos recently uncovered. Dr. Paxinos joins Dr. Andrew Wilner to discuss the endorestiform nucleus, the new anatomical structure in the brain he found using his own

00:00:00

Beyond Medication: Treatment Options for...

Neurology and Neurosurgery ·

2017/12/11

Host: David Weisman, MD It is estimated that approximately 30% of epilepsy patients are drug-resistant, meaning their seizures do not successfully respond to anti-seizure medications. What other treatment options are available to patients who aren’t responding to medication? Host Dr. David Weisman chats with Dr. Lara Marcuse, Co-Director of Mount Sinai Epilepsy Center, about new and emerging treatment options for epilepsy.

00:00:00

Neuromodulation Therapy: Emerging Treatment Option...

Neurology and Neurosurgery ·

2017/11/17

Host: Andrew Wilner, MD, FACP, FAAN While most people with epilepsy are treated with medications, other modalities such as surgery, diet, and neuromodulation are often necessary. Since the FDA approval of the vagus nerve stimulator in 1997, there has been a growing interest in neuromodulation. A second, more sophisticated device, the responsive neurostimulator, received FDA approval in 2013. Host Andrew Wilner talks with Dr. Robert Fisher, Professor of Neurology and Director of the

00:00:00

Sudden Unexplained Death in Epilepsy (SUDEP): Risks...

Neurology and Neurosurgery ·

2017/07/23

Host: Andrew Wilner, MD, FACP, FAAN Guest: Elizabeth Donner, MD Sudden Unexplained Death in Epilepsy (SUDEP) refers to the unexplained death of a seemingly healthy person with epilepsy where no cause of death can be found. What do doctors need to know about this mysterious and devastating phenomenon? Dr. Elizabeth Donner, Director of the Comprehensive Epilepsy Program and Associate Professor in the Department of Pediatrics at the University of Toronto joins host Dr. Andrew Wilner

00:00:00

Autism in Adults: Special Challenges and Therapeutic...

Neurology and Neurosurgery ·

2014/12/22

Host: Paul Rokuskie Autism is not just a child matter. As the prevelance rates of autism continue to rise, so do the numbers of patients entering adulthood. What are the special challenges faced by these patients, their families, and the clinicians who treat and counsel them both respectively? And how can updated therapeutic approaches help change the life trajectories for adults with autism? Host Paul Rokuskie welcomes Dr. Marsha Mailick, Interim Vice Chancellor for Research and

00:00:00

Alzheimer's Association: A Partner in Health Care for...

Neurology and Neurosurgery ·

2014/07/08

Host: Ana Maria Rosario Senior correspondent Ana Maria Rosario chats with Kate Williams, LMSW, from the Alzheimer's Association's Greater Michigan Chapter. Ms. Williams discusses the prevalence of Alzheimer's disease, the myths and misconceptions, and morbidity and mortality statistics, particularly in women. The risk of Alzheimer's disease in women is 1 in 6, compared to the risk of breast cancer, which is 1 in 12. Physicians and other health care providers are encouraged to visit

00:00:00

Tuberous Sclerosis Complex (TSC) Diagnosis & Clinical...

Neurology and Neurosurgery ·

2014/04/03

Host: Michael Greenberg, MD First described in the 1880s, tuberous sclerosis complex, or TSC, is a genetic disease that affects multiple organs. It can cause tumors in the skin, kidneys, brain, heart, eyes, as well as other organ systems. Most patients who are mildly affected by TSC lead active and productive lives, but it is important to note that TSC is a life-long companion and patients are in need of receiving continuous follow-up care. Host Dr. Michael Greenberg welcomes Steven L

00:00:00

A Balance of Practicing Medicine and Pursuing Your...

Neurology and Neurosurgery ·

2014/01/30

Host: Tim Rush In such a challenging and time-consuming profession, how can physicians find time to pursue other passions? Host Tim Rush welcomes Dr. Andrew Wilner, neurologist and award-winning author. His latest book, Bullets and Brains, draws on his own experiences as a neurologist to explain, in everyday terms, the dangers that can impact the brain. Dr. Wilner will discuss his career as both physician and author, including his medical missions in the Philippines. Download and

141 results

Neurology and Neurosurgery

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事